Outpatient Surgery Magazine - Subscribers

OR Excellence Awards 2015 - September 2015 - Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://magazine.outpatientsurgery.net/i/567827

Contents of this Issue

Navigation

Page 80 of 168

WE TAKE PAIN PERSONALLY REASON #10 ON!Q * IS DESIGNED TO HIT THE MARK. † Clinicians need a more e!ective and predictable alternative to single shots and long-acting locals for patients. The ON-Q* Pain Relief System lets you tailor the treatment to deliver up to 120 hours of e!ective non-narcotic, post op relief. 1 That's up to 5x longer than EXPAREL ® , which has been shown to provide up to only 24 hours of pain relief. 2-3 ON-Q* gives clinicians more control over their pain management therapy options for dependable post surgical pain management. The result? Personalized pain management that has been proven to lower reported pain scores by up to 69%. 4 —that's right on target for everyone. FOR MORE INFORMATION CALL 800Ä 448Å3569 OR VISIT FACTVSFICTION.INFO † For up to 120 hours of e#ective non-narcotic, post op pain relief. There are inherent risks in all medical devices. Please refer to the product labeling for Indications, Cautions, Warnings, and Contraindications. Failure to follow the product labeling could directly impact patient safety. Physician is responsible for prescribing and administering medications per instructions provided by the drug manufacturer. Refer to www.halyardhealth.com for product safety Technical Bulletins. 1. Data on file. 2. Golf M, Daniels SE, Onel E. A Phase III, randomized, placebo controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther. Sep 2011;28(9):776-788. 3. Gorfine SR, Onel E, Patou G, et al. Bupivacaine extended- yelease liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: A multicenter, randomized, double- blind, placebo-controlled trial. Dis Colon Rectum. Dec. 2011;54(12):1552-1559. 4. Sherwinter DA, et al. Continuous infusion of interperitoneal bupivacaine after laparoscopic Surgery: A randomized controlled trial. Obes Surg. 2008: 18 (12): 1581-6. ON-Q* Pain Relief System. *Registered Trademark or Trademark of Halyard Health, Inc. or its a#liates. © 2015 HYH. All rights reserved. RX Only. MK-00749 PAIN MANAGEMENT YOU CAN DEPEND ON.

Articles in this issue

Links on this page

Archives of this issue

view archives of Outpatient Surgery Magazine - Subscribers - OR Excellence Awards 2015 - September 2015 - Outpatient Surgery Magazine